To enable broader use of clinical data in its digital health care system, Japan has kickstarted digitization measures to link all patient records to an online individual ID system. While the government aims to allow real-world data and evidence for the pharmaceutical sector in the long run, The Pink Sheet explores the reality of current projects and measures in the country.
Looking at the need for optimized drug R&D and wider adoption of precision healthcare, the use of real-world data (RWD) has been a recent hot topic in Japan.
But without a common data platform for handling clinical records on a nationwide scale, the country’s adoption of RWD systems has been